Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 4 | 2020 | 1527 | 1.300 |
Why?
|
Agammaglobulinemia | 4 | 2022 | 167 | 1.270 |
Why?
|
Bayes Theorem | 3 | 2019 | 2303 | 0.940 |
Why?
|
Inappropriate Prescribing | 2 | 2017 | 202 | 0.930 |
Why?
|
Patient Transfer | 4 | 2011 | 760 | 0.770 |
Why?
|
Immune System Diseases | 1 | 2023 | 262 | 0.770 |
Why?
|
Health Status Disparities | 2 | 2023 | 1794 | 0.730 |
Why?
|
Medical Errors | 7 | 2016 | 1296 | 0.690 |
Why?
|
Mesalamine | 1 | 2016 | 136 | 0.540 |
Why?
|
Insurance Claim Review | 1 | 2020 | 720 | 0.540 |
Why?
|
False Positive Reactions | 2 | 2016 | 981 | 0.540 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 590 | 0.520 |
Why?
|
Biological Factors | 1 | 2016 | 164 | 0.520 |
Why?
|
Classification | 2 | 2017 | 129 | 0.510 |
Why?
|
Continuity of Patient Care | 2 | 2013 | 1048 | 0.500 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 438 | 0.490 |
Why?
|
Early Detection of Cancer | 4 | 2017 | 3070 | 0.480 |
Why?
|
Risk Management | 4 | 2015 | 571 | 0.480 |
Why?
|
Medical Informatics | 7 | 2016 | 742 | 0.480 |
Why?
|
Population Surveillance | 2 | 2014 | 2616 | 0.430 |
Why?
|
Biological Products | 1 | 2021 | 856 | 0.420 |
Why?
|
Urban Population | 1 | 2020 | 2018 | 0.420 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 783 | 0.420 |
Why?
|
Drug Interactions | 1 | 2017 | 1458 | 0.420 |
Why?
|
Suicide, Attempted | 1 | 2020 | 1218 | 0.410 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2012 | 108 | 0.410 |
Why?
|
Transportation of Patients | 1 | 2013 | 185 | 0.410 |
Why?
|
Antirheumatic Agents | 1 | 2021 | 1335 | 0.400 |
Why?
|
Signal Detection, Psychological | 1 | 2011 | 85 | 0.400 |
Why?
|
Patient Selection | 1 | 2023 | 4214 | 0.390 |
Why?
|
Mammography | 3 | 2017 | 2474 | 0.370 |
Why?
|
Rural Population | 1 | 2020 | 2207 | 0.360 |
Why?
|
Secondary Prevention | 1 | 2016 | 1520 | 0.360 |
Why?
|
Respiratory Sounds | 1 | 2014 | 693 | 0.350 |
Why?
|
Benzodiazepines | 1 | 2015 | 1101 | 0.340 |
Why?
|
Infection Control | 3 | 2013 | 962 | 0.340 |
Why?
|
Alcoholism | 1 | 2019 | 1904 | 0.330 |
Why?
|
Insurance, Health | 2 | 2019 | 2493 | 0.320 |
Why?
|
Reminder Systems | 1 | 2011 | 370 | 0.320 |
Why?
|
Databases, Factual | 5 | 2017 | 7716 | 0.310 |
Why?
|
Automation | 1 | 2010 | 584 | 0.310 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 7901 | 0.310 |
Why?
|
Prostate-Specific Antigen | 1 | 2017 | 2458 | 0.290 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2276 | 0.280 |
Why?
|
Social Support | 2 | 2015 | 2117 | 0.280 |
Why?
|
Mental Health | 1 | 2020 | 2997 | 0.270 |
Why?
|
Equipment Failure Analysis | 3 | 2015 | 867 | 0.270 |
Why?
|
Safety Management | 2 | 2015 | 782 | 0.260 |
Why?
|
Guideline Adherence | 2 | 2013 | 2266 | 0.260 |
Why?
|
Child | 12 | 2023 | 77478 | 0.260 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 950 | 0.260 |
Why?
|
Length of Stay | 1 | 2018 | 6294 | 0.250 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2062 | 0.250 |
Why?
|
Algorithms | 3 | 2020 | 13853 | 0.240 |
Why?
|
Retrospective Studies | 14 | 2022 | 77098 | 0.240 |
Why?
|
Pediatrics | 1 | 2019 | 3462 | 0.240 |
Why?
|
Crohn Disease | 1 | 2016 | 2301 | 0.230 |
Why?
|
Registries | 1 | 2019 | 8077 | 0.230 |
Why?
|
Radiology Department, Hospital | 3 | 2013 | 412 | 0.230 |
Why?
|
Humans | 44 | 2023 | 742088 | 0.220 |
Why?
|
United States | 11 | 2023 | 69693 | 0.210 |
Why?
|
Warts | 1 | 2022 | 68 | 0.210 |
Why?
|
Health Expenditures | 1 | 2015 | 2346 | 0.210 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2130 | 0.210 |
Why?
|
Adolescent | 10 | 2022 | 85649 | 0.210 |
Why?
|
Nijmegen Breakage Syndrome | 1 | 2021 | 5 | 0.200 |
Why?
|
Disease Progression | 4 | 2023 | 13256 | 0.190 |
Why?
|
Mass Screening | 4 | 2018 | 5238 | 0.190 |
Why?
|
New South Wales | 2 | 2018 | 66 | 0.190 |
Why?
|
Asthma | 2 | 2021 | 5955 | 0.180 |
Why?
|
Founder Effect | 1 | 2021 | 190 | 0.180 |
Why?
|
Lymphopenia | 1 | 2022 | 285 | 0.180 |
Why?
|
Breast Neoplasms | 3 | 2017 | 20774 | 0.180 |
Why?
|
Interprofessional Relations | 2 | 2017 | 1008 | 0.180 |
Why?
|
Adult | 13 | 2022 | 213712 | 0.170 |
Why?
|
Common Variable Immunodeficiency | 1 | 2019 | 93 | 0.170 |
Why?
|
Communication | 1 | 2013 | 3728 | 0.170 |
Why?
|
Inpatients | 1 | 2010 | 2495 | 0.160 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2022 | 546 | 0.160 |
Why?
|
Artificial Intelligence | 1 | 2012 | 2187 | 0.160 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7276 | 0.160 |
Why?
|
Epilepsy | 1 | 2014 | 3301 | 0.160 |
Why?
|
Young Adult | 6 | 2022 | 56350 | 0.160 |
Why?
|
Lymphoproliferative Disorders | 1 | 2021 | 525 | 0.150 |
Why?
|
Neutropenia | 1 | 2022 | 891 | 0.150 |
Why?
|
Rare Diseases | 1 | 2022 | 554 | 0.150 |
Why?
|
Survival Analysis | 2 | 2020 | 10248 | 0.140 |
Why?
|
American Cancer Society | 1 | 2016 | 61 | 0.140 |
Why?
|
Female | 16 | 2021 | 379592 | 0.140 |
Why?
|
Hospitals, Urban | 1 | 2018 | 499 | 0.140 |
Why?
|
Hospitals, Teaching | 2 | 2011 | 1179 | 0.140 |
Why?
|
Equipment Failure | 2 | 2015 | 579 | 0.130 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7153 | 0.130 |
Why?
|
North America | 1 | 2019 | 1249 | 0.130 |
Why?
|
Prevalence | 5 | 2021 | 15194 | 0.130 |
Why?
|
Child, Preschool | 5 | 2021 | 40955 | 0.130 |
Why?
|
Male | 14 | 2021 | 349538 | 0.130 |
Why?
|
Unnecessary Procedures | 1 | 2018 | 431 | 0.120 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11039 | 0.120 |
Why?
|
Ileum | 1 | 2016 | 565 | 0.120 |
Why?
|
Computer Communication Networks | 1 | 2015 | 295 | 0.120 |
Why?
|
Comorbidity | 2 | 2019 | 10372 | 0.120 |
Why?
|
Middle Aged | 10 | 2020 | 213127 | 0.120 |
Why?
|
Insurance Claim Reporting | 1 | 2014 | 163 | 0.110 |
Why?
|
Research | 1 | 2022 | 1999 | 0.110 |
Why?
|
Organizational Case Studies | 2 | 2011 | 299 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2021 | 2107 | 0.110 |
Why?
|
Genome, Viral | 1 | 2016 | 667 | 0.110 |
Why?
|
Consensus | 1 | 2021 | 2935 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2019 | 2713 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2012 | 5062 | 0.100 |
Why?
|
Colectomy | 1 | 2016 | 681 | 0.100 |
Why?
|
Postoperative Period | 1 | 2016 | 1839 | 0.100 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1246 | 0.100 |
Why?
|
Public Opinion | 1 | 2015 | 477 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2043 | 0.090 |
Why?
|
User-Computer Interface | 2 | 2015 | 1426 | 0.090 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4554 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 925 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1952 | 0.090 |
Why?
|
Vitamin B 6 Deficiency | 1 | 2009 | 17 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1707 | 0.090 |
Why?
|
Observation | 1 | 2011 | 312 | 0.090 |
Why?
|
Data Mining | 1 | 2015 | 537 | 0.090 |
Why?
|
Cohort Studies | 4 | 2018 | 40450 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2017 | 1503 | 0.090 |
Why?
|
Odds Ratio | 1 | 2022 | 9846 | 0.090 |
Why?
|
Age Factors | 2 | 2017 | 18355 | 0.090 |
Why?
|
Regression Analysis | 1 | 2019 | 6452 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3444 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1820 | 0.080 |
Why?
|
Computer Systems | 1 | 2010 | 483 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 831 | 0.080 |
Why?
|
Folic Acid Deficiency | 1 | 2009 | 115 | 0.080 |
Why?
|
Hepacivirus | 1 | 2016 | 1372 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2019 | 19862 | 0.080 |
Why?
|
Papillomavirus Vaccines | 1 | 2015 | 489 | 0.080 |
Why?
|
Colon | 1 | 2016 | 1773 | 0.080 |
Why?
|
Computer Simulation | 2 | 2012 | 6191 | 0.080 |
Why?
|
Research Report | 1 | 2011 | 355 | 0.080 |
Why?
|
Cause of Death | 1 | 2018 | 3571 | 0.080 |
Why?
|
Aged | 6 | 2020 | 162944 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2030 | 0.070 |
Why?
|
Femur Head | 1 | 2009 | 301 | 0.070 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2011 | 430 | 0.070 |
Why?
|
United States Food and Drug Administration | 2 | 2011 | 1581 | 0.070 |
Why?
|
Natural Language Processing | 2 | 2015 | 1035 | 0.070 |
Why?
|
Safety | 1 | 2011 | 1185 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3510 | 0.070 |
Why?
|
Medical Order Entry Systems | 1 | 2011 | 544 | 0.070 |
Why?
|
Hepatitis C | 1 | 2016 | 1582 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5851 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1636 | 0.070 |
Why?
|
Patient Discharge | 1 | 2018 | 3300 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2010 | 824 | 0.060 |
Why?
|
Infant | 2 | 2019 | 35070 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8333 | 0.060 |
Why?
|
Risk Factors | 4 | 2021 | 72145 | 0.060 |
Why?
|
Patient Care Team | 1 | 2015 | 2527 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2021 | 62966 | 0.060 |
Why?
|
Causality | 1 | 2010 | 1265 | 0.060 |
Why?
|
Information Dissemination | 1 | 2011 | 1100 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9410 | 0.050 |
Why?
|
Vaccination | 1 | 2015 | 3256 | 0.050 |
Why?
|
Medicare | 1 | 2020 | 6532 | 0.050 |
Why?
|
Europe, Eastern | 1 | 2021 | 75 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 5979 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39004 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2012 | 3584 | 0.050 |
Why?
|
Receptors, Glucocorticoid | 1 | 2021 | 302 | 0.040 |
Why?
|
Health Personnel | 1 | 2013 | 3210 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 24913 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2019 | 25575 | 0.040 |
Why?
|
Workflow | 2 | 2015 | 846 | 0.040 |
Why?
|
Bone and Bones | 1 | 2009 | 2575 | 0.040 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2009 | 1461 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2021 | 550 | 0.040 |
Why?
|
Receptors, CXCR4 | 1 | 2022 | 726 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 992 | 0.040 |
Why?
|
Risk Assessment | 2 | 2016 | 23320 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5304 | 0.040 |
Why?
|
Bone Density | 1 | 2009 | 3469 | 0.040 |
Why?
|
Prospective Studies | 2 | 2011 | 53187 | 0.030 |
Why?
|
Software Design | 1 | 2016 | 176 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1866 | 0.030 |
Why?
|
Viral Nonstructural Proteins | 1 | 2016 | 241 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 194 | 0.030 |
Why?
|
Computer Security | 1 | 2016 | 263 | 0.030 |
Why?
|
England | 1 | 2015 | 523 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 814 | 0.030 |
Why?
|
State Medicine | 1 | 2015 | 220 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1847 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2018 | 956 | 0.030 |
Why?
|
Consumer Product Safety | 1 | 2011 | 122 | 0.020 |
Why?
|
Patient Identification Systems | 1 | 2011 | 79 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2638 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2699 | 0.020 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2009 | 116 | 0.020 |
Why?
|
Virus Replication | 1 | 2016 | 2531 | 0.020 |
Why?
|
RNA, Viral | 1 | 2016 | 2899 | 0.020 |
Why?
|
Australia | 1 | 2010 | 1167 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1477 | 0.020 |
Why?
|
Government Regulation | 1 | 2011 | 522 | 0.020 |
Why?
|
Vitamin B 12 | 1 | 2009 | 527 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4664 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2183 | 0.020 |
Why?
|
Attitude to Health | 1 | 2015 | 2051 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1162 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12344 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 2978 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1726 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9826 | 0.010 |
Why?
|
Body Height | 1 | 2009 | 1574 | 0.010 |
Why?
|
Folic Acid | 1 | 2009 | 1300 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12220 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20928 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15494 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10163 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15994 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15530 | 0.010 |
Why?
|
Osteoporosis | 1 | 2009 | 1581 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 12730 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4664 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2015 | 4440 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21719 | 0.010 |
Why?
|
Software | 1 | 2011 | 4434 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81045 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168561 | 0.000 |
Why?
|
Concepts
(228)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_